Skip to search formSkip to main contentSkip to account menu

Sinemet CR

Known as: Sinemet CR4, cr sinemet 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Carbidopa / Levodopa
Sinemet

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Quality of life in patients with Parkinson’s disease who transfer from standard levodopa to Sinemet CR: the STAR study
Abstract Conversion from standard levodopa to Sinemet CR was performed in a series of 450 patients with Parkinson’s disease. Of… 
Review
1998
Review
1998
Pharmacoeconomic Analysis of Using Sinemet CR over Standard Sinemet in Parkinsonian Patients with Motor Fluctuations
OBJECTIVE: To compare the costs of pharmacotherapy in patients with Parkinson's disease before and after converting from standard… 
Highly Cited
1996
Highly Cited
1996
Optical spectroscopy of Cr4+-doped Ca2GeO4 and Mg2SiO4.
Polarized single crystal absorption spectra and luminescence spectra of ${\mathrm{Cr}}^{4+}$-doped ${\mathrm{Ca}}_{2}$${\mathrm… 
1995
1995
Resonance Raman scattering in Cr4+-doped forsterite.
1992
1992
The use of Sinemet CR in the management of mild to moderate Parkinson's disease
The pharmacokinetic advantage of controlled-release carbidopa-levodopa (Sinemet CR) is its slow dissolution and gradual… 
1989
1989
An open multicenter long-term treatment evaluation of Sinemet CR. Sinemet CR Multicenter Study Group.
The safety and efficacy of Sinemet CR were studied in an open-label, 52-week trial. The study was completed by 156 mildly to… 
1989
1989
Double-blind comparison of standard Sinemet and Sinemet CR in patients with mild-to-moderate Parkinson's disease.
The combination of carbidopa and levodopa (Sinemet) is a highly effective treatment for the symptoms of Parkinson's disease… 
1989
1989
Long-term clinical efficacy of Sinemet CR in patients with Parkinson's disease.
Sinemet CR, a controlled-release form of carbidopa/levodopa, was administered for 36 or 39 months to 8 patients with Parkinson's… 
1989
1989
Efficacy of sinemet CR4 in subgroups of patients with Parkinson's disease.
The efficacy of Sinemet CR4 (50/200) was compared to standard Sinemet (25/100) in an open label crossover study in 22 patients… 
Highly Cited
1987
Highly Cited
1987
Controlled‐release levodopa/carbidopa.
Sixteen patients with Parkinson's disease and therapeutic response fluctuations entered an open-label trial of a controlled… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)